Global and regional incidence, mortality and disability-adjusted life-years for Epstein-Barr virus-attributable malignancies, 1990–2017

Global and regional incidence, mortality and disability-adjusted life-years for Epstein-Barr virus-attributable malignancies, 1990–2017

Bibliographic Details
Main Authors:	Mohsen Naghavi, Gulfaraz Khan, Christina Fitzmaurice
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-08-01
Series:	BMJ Open
Online Access:	https://bmjopen.bmj.com/content/10/8/e037505.full

Similar Items

High incidence of Epstein-Barr virus infection in childhood acute lymphocytic leukemia
by: Khan Gulfaraz
Published: (2010-10-01)

The association of Epstein-Barr virus infection with multiple myeloma
by: Gulfaraz Khan
Published: (2012-01-01)

Epstein-Barr Virus and miRNAs: Partners in Crime in the Pathogenesis of Multiple Sclerosis?
by: Asma Hassani, et al.
Published: (2019-04-01)

The Microenvironment in Epstein–Barr Virus-Associated Malignancies
by: Geok Wee Tan, et al.
Published: (2018-04-01)

Molecular Genetics in Epstein–Barr Virus-Associated Malignancies
by: Srikanth Umakanthan, et al.
Published: (2021-06-01)

Trends in prevalence and mortality burden attributable to smoking, Brazil and federated units, 1990 and 2017
by: Deborah Carvalho Malta, et al.
Published: (2020-09-01)

Epstein-Barr virus in normal and malignant human nasopharyngeal epithelia
by: Tugwood, J. D.
Published: (1986)

Chronic Active Epstein–Barr Virus Infection: Is It Immunodeficiency, Malignancy, or Both?
by: Shigeyoshi Fujiwara, et al.
Published: (2020-10-01)

Epstein–Barr Virus-Associated Malignancies: Roles of Viral Oncoproteins in Carcinogenesis
by: Ahmed El-Sharkawy, et al.
Published: (2018-08-01)

Multiple Sclerosis and Epstein-Barr Virus
by: Ruth Ann Marrie, et al.
Published: (2002-01-01)

Epstein-Barr virus-encoded small RNAs (EBERs) are present in fractions related to exosomes released by EBV-transformed cells.
by: Waqar Ahmed, et al.
Published: (2014-01-01)

Advances in Virus-Directed Therapeutics against Epstein-Barr Virus-Associated Malignancies
by: Sajal K. Ghosh, et al.
Published: (2012-01-01)

Epstein-Barr Virus MicroRNA Expression Increases Aggressiveness of Solid Malignancies.
by: Deep Pandya, et al.
Published: (2015-01-01)

EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOID MALIGNANCIES : THE EXPANDING SPECTRUM OF HEMATOPOIETIC NEOPLASMS
by: Ito, Yoshinori, et al.
Published: (2013)

Epstein–Barr Virus Infection of Mammary Epithelial Cells Promotes Malignant Transformation
by: Hai Hu, et al.
Published: (2016-07-01)

Disability-adjusted life years associated with population ageing in China, 1990-2017
by: Ruotong Li, et al.
Published: (2021-06-01)

Global trends in the incidence and mortality of esophageal cancer from 1990 to 2017
by: Jiahui Fan, et al.
Published: (2020-09-01)

Epstein-Barr Virus New Trends
Published: (2021)

Pathogenesis of epstein-barr virus-
by: 賴宗鼎
Published: (1997)

Benign Gastric Ulcer with Epstein-Barr Virus Infection Mimicking Malignant Gastric Ulcer
by: Jin Wuk Gwak, et al.
Published: (2019-03-01)

Chronic Epstein-Barr virus infection causing both benign and malignant lymphoproliferative disorders
by: Yoojin Kwun, et al.
Published: (2014-09-01)

The role of latent membrane protein 2 in the pathogenesis of Epstein-Barr virus associated malignancy
by: Jia, Junying
Published: (2006)

The burden of malaria in Sudan: incidence, mortality and disability – adjusted life – years
by: Malik Elfatih M, et al.
Published: (2007-07-01)

Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells.
by: Asma Hassani, et al.
Published: (2018-01-01)

Potential Cellular Functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus
by: Danielle Westhoff Smith, et al.
Published: (2013-01-01)

Soro-epidemiologia do virus de Epstein-Barr (VEB) The seroepidemiology of the Epstein-Barr vírus (EBV)
by: Claudio Sergio Pannuti
Published: (1981-02-01)

Epstein–Barr Virus: A Biological Overview and Clinicopathological Changes of Two Epstein–Barr Virus-Related Lymphoproliferative Disorders in a World Health Organization (WHO) 2017 Report
by: Cristiano Claudino Oliveira
Published: (2018-09-01)

Temporal Trends in the Incidence and Mortality of Skin Malignant Melanoma in China from 1990 to 2019
by: Ruhai Bai, et al.
Published: (2021-01-01)

No evidence for the presence of Epstein-Barr virus in squamous cell carcinoma of the mobile tongue.
by: Torben Wilms, et al.
Published: (2017-01-01)

Lytic Induction Therapy against Epstein–Barr Virus-Associated Malignancies: Past, Present, and Future
by: Stephanie Pei Tung Yiu, et al.
Published: (2020-08-01)

Epstein-Barr Virus and Human Adenovirus Viremia in Renal Tumors Is Associated with Histological Features of Malignancy
by: Piotr Kryst, et al.
Published: (2020-10-01)

Primary Lung Cancer Complicated by Malignant Lymphoma in Two Cases of Epstein-Barr Virus Infection
by: Zentaro Ohno, et al.
Published: (2012-07-01)

Emerging Roles of Small Epstein-Barr Virus Derived Non-Coding RNAs in Epithelial Malignancy
by: Ka-Fai To, et al.
Published: (2013-08-01)

Hypersensitivity to mosquito bites: A versatile Epstein–Barr virus disease with allergy, inflammation, and malignancy
by: Masaki Yamada, et al.
Published: (2021-10-01)

Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus
by: Mohsen eNavari, et al.
Published: (2014-12-01)

Epstein-Barr Virus and Multiple Sclerosis
by: Gunnar Houen, et al.
Published: (2020-12-01)

Epstein–Barr virus and multiple sclerosis
by: A. I. Skliar, et al.
Published: (2020-12-01)

Epstein-Barr Virus-induced Jaundice
by: Jessica Herold, et al.
Published: (2020-02-01)

Epstein-Barr Virus Neurologic Complications
by: J. Gordon Millichap
Published: (2015-12-01)

Novel Therapeutics for Epstein–Barr Virus
by: Graciela Andrei, et al.
Published: (2019-03-01)